214 related articles for article (PubMed ID: 7120315)
1. Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities.
McColl KE; Moore MR; Thompson GG; Goldberg A
J Med Genet; 1982 Aug; 19(4):271-6. PubMed ID: 7120315
[TBL] [Abstract][Full Text] [Related]
2. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.
Lamon JM; Frykholm BC; Tschudy DP
J Med Genet; 1979 Apr; 16(2):134-9. PubMed ID: 458830
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
Forman DT
Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
[TBL] [Abstract][Full Text] [Related]
4. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
Sassa S; Zalar GL; Kappas A
J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
[TBL] [Abstract][Full Text] [Related]
5. Experience with the red cell uroporphyrinogen synthase (URO-S) assay in kindreds with acute intermittent porphyria (AIP).
Kreimer-Birnbaum M; Bonkowsky HL; Bottomley SS
Int J Biochem; 1980; 12(5-6):807-10. PubMed ID: 7450137
[No Abstract] [Full Text] [Related]
6. The activities of the enzymes of haem biosynthesis in the porphyrias and during treatment of acute intermittent porphyrias.
Moore MR; McColl KE; Goldberg A
Int J Biochem; 1980; 12(5-6):941-6. PubMed ID: 7450153
[No Abstract] [Full Text] [Related]
7. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity.
Mustajoki P; Tenhunen R
Eur J Clin Invest; 1985 Oct; 15(5):281-4. PubMed ID: 3935460
[TBL] [Abstract][Full Text] [Related]
8. Carbamazepine-induced non-hereditary acute porphyria.
Yeung Laiwah AA; Rapeport WG; Thompson GG; Macphee GJ; Philip MF; Moore MR; Brodie MJ; Goldberg A
Lancet; 1983 Apr; 1(8328):790-2. PubMed ID: 6132132
[TBL] [Abstract][Full Text] [Related]
9. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
Sassa S; Solish G; Levere RD; Kappas A
J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
[TBL] [Abstract][Full Text] [Related]
10. Red cell uroporphyrinogen I synthetase in acute intermittent porphyria.
Mustajoki P
Ann Clin Res; 1976; 8 Suppl 17():133-8. PubMed ID: 1008483
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
[TBL] [Abstract][Full Text] [Related]
12. The measurement of erythrocyte uroporphyrinogen 1 synthase in the diagnosis of latent and acute intermittent porphyria.
Brocklehurst D; Wider de Xifra EA; Batlle A
Int J Biochem; 1980; 12(5-6):791-3. PubMed ID: 7450134
[No Abstract] [Full Text] [Related]
13. [Uroporphyrinogen synthase in erythrocytes in acute intermittent porphyria: new pathobiochemical aspects (author's transl)].
Doss M; von Tiepermann R
J Clin Chem Clin Biochem; 1978 Feb; 16(2):111-8. PubMed ID: 624910
[TBL] [Abstract][Full Text] [Related]
14. [Acute intermittent porphyria. Familial study: detection of latent cases by the determination of erythrocyte uroporphyrinogen-1-synthetase activity].
Guijarro Merino R; Villar Ortiz J; Lapetra Peralta J; Melero Bellido M; García Donas MA; Carneado de la Fuente J
Med Clin (Barc); 1986 Mar; 86(8):323-7. PubMed ID: 3713356
[No Abstract] [Full Text] [Related]
15. Low-cost uroporphyrinogen I synthase screening for acute intermittent porphyria.
Brocklehurst D
Clin Chem; 1978 Apr; 24(4):730-1. PubMed ID: 639289
[No Abstract] [Full Text] [Related]
16. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
Iwanov ED; Adjarov D; Tsanev R
Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
[TBL] [Abstract][Full Text] [Related]
17. Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings].
Brodie MJ; Moore MR; Thompson GG; Campbell BC; Goldberg A
Biochem Soc Trans; 1977; 5(5):1466-8. PubMed ID: 923960
[No Abstract] [Full Text] [Related]
18. The diagnosis of acute intermittent porphyria. Usefulness and limitations of the erythrocyte uroporphyrinogen I synthase assay.
Bottomley SS; Bonkowsky HL; Kreimer-Birnbaum M
Am J Clin Pathol; 1981 Aug; 76(2):133-9. PubMed ID: 7270494
[TBL] [Abstract][Full Text] [Related]
19. Haem biosynthesis in cutaneous hepatic porphyria: comparison with alcoholism and liver disease.
Brodie MJ; Thompson GG; Moore MR; McColl KE; Goldberg A; Hardie RA; Hunter JA
Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):122-8. PubMed ID: 463487
[TBL] [Abstract][Full Text] [Related]
20. Effect of carbamazepine on haem biosynthesis in man.
Rapeport WG; Connell JC; Thompson GG; Moore MR; Brodie MJ
Eur J Clin Invest; 1984 Apr; 14(2):107-10. PubMed ID: 6428897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
